SMAD4 and familial pancreatic carcinoma: Jazag et al. [23] established Smad4 knockdown (S4KD) pancreatic cancer cell lines and screened for the targeted molecules downstream of TGF-beta using cDNA microarray and found that the signaling pathways were different according to the Smad4 status.